US Patent Issued to Ascentage Pharma (Suzhou), Ascentage Pharma Group on March 17 for "Sulfonyl benzamide derivatives as Bcl-2 inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,245, issued on March 17, was assigned to Ascentage Pharma (Suzhou) Co. Ltd. (China) and Ascentage Pharma Group Corp Ltd. (China).

"Sulfonyl benzamide derivatives as Bcl-2 inhibitors" was invented by Dongbo Li (Suzhou, China), Jianyong Chen (Suzhou, China), Fang Liu (Suzhou, China), Hao Chen (Suzhou, China) and Xianchan Zha (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein variables are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I for use to treat ...